Telix Pharmaceuticals Limited Reaffirms Revenue Guidance for the Year 2024
USD 445 million to USD 465 million (AUD 675 million to AUD 705 million at current exchange rates), representing an approximate 35-40% increase versus 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.45 AUD | +2.52% | +1.11% | +53.27% |
1st Jan change | Capi. | |
---|---|---|
+53.27% | 3.33B | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |